RTW Investments, LP 13D/13G Filings for Spyre Therapeutics, Inc. (SYRE)

RTW Investments, LP 13D and 13G filings for Spyre Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
09:00 am
Purchase		 2024-12-31 13G Spyre Therapeutics, Inc.
SYRE		 RTW Investments, LP 3,621,996
6.200%		 1,389,236increase
(+62.22%)		 Filing
2024-02-14
07:02 am
Purchase		 2023-12-31 13G Spyre Therapeutics, Inc.
SYRE		 RTW Investments, LP 2,232,760
6.200%		 2,232,760increase
(New Position)		 Filing